Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

clinical trialsClinicalTrials.govT1Dtrial matching

What this is and is not

This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.

A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?

Recruiting records to inspect

Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment — RECRUITING, PHASE2. Interventions: Semaglutide Pen Injector, Placebo. Locations: New Haven, Connecticut, United States. More than 40% of young adults with type 1 diabetes (T1D) also have overweight or obesity. Each of t...Source
Denosumab for Type 1 Diabetes — RECRUITING, PHASE1, PHASE2. Interventions: Denosumab, Placebo. Locations: Birmingham, Alabama, United States | Duarte, California, United States | Indianapolis, Indiana, United States. Type 1 diabetes (T1D) arises from...Source
Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes — RECRUITING. Interventions: Advanced artificial pancreas closed-loop technology. Locations: Jacksonville, Florida, United States | Orlando, Florida, United States. 50 children/adolescents (ages 6 to \<18yrs) with T1D in...Source
Restoration of Hypoglycemia Awareness With Metoclopramide — RECRUITING, PHASE2. Interventions: Metoclopramide, Placebo. Locations: Lexington, Kentucky, United States | Salt Lake City, Utah, United States. Metoclopramide is a drug approved by the FDA for gastroesophageal reflux a...Source
Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes — RECRUITING, PHASE2. Interventions: Insulin, Semaglutide, Empagliflozin. Locations: Tanta, Egypt. Type 1 Diabetes (T1DM) is a disease characterised by immune mediated destruction of the insulin-producing pancreatic beta...Source
A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM) — RECRUITING, PHASE1. Interventions: LY3938577, Placebo, Insulin Degludec. Locations: Neuss, Germany. The main purpose of this study is to look at the amount of the study drug LY3938577 that gets into the blood stream and...Source
Diabetes in African Youth — RECRUITING, PHASE4. Interventions: Libre 2, Device for SMBG and Libre Pro. Locations: Minneapolis, Minnesota, United States. This RCT aims to improve T1D care in East African children and young adults by testing the hyp...Source
Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART — RECRUITING, NA. Interventions: ReCharge, TakeCharge. Locations: Chapel Hill, North Carolina, United States. This study is designed to compare two behavioral approaches to reduce diabetes distress ("the expected burdens,...Source

Questions before contacting a study

Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
Can the family discuss the official record with their endocrinology team before sharing additional personal health details?

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.